Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile five years following lenadogene nolparvovec gene therapy in patients with ...

Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...

Brain stimulation therapies use electrical currents to alter the brain’s activity. They can treat conditions such as major depression and substance misuse disorder. However, side effects such as ...

Whether we’re staring at our phones, the page of a book, or the person across the table, the objects of our focus never stand in isolation; there are always other objects or people in our field of ...